Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
Crossref DOI link: https://doi.org/10.1007/s13238-017-0440-4
Published Online: 2017-07-14
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feng, Kaichao
Liu, Yang
Guo, Yelei
Qiu, Jingdan
Wu, Zhiqiang
Dai, Hanren
Yang, Qingming
Wang, Yao
Han, Weidong
Text and Data Mining valid from 2017-07-14